Correlation Between Reata Pharmaceuticals and Anavex Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Reata Pharmaceuticals and Anavex Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reata Pharmaceuticals and Anavex Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reata Pharmaceuticals and Anavex Life Sciences, you can compare the effects of market volatilities on Reata Pharmaceuticals and Anavex Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reata Pharmaceuticals with a short position of Anavex Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reata Pharmaceuticals and Anavex Life.

Diversification Opportunities for Reata Pharmaceuticals and Anavex Life

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between Reata and Anavex is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Reata Pharmaceuticals and Anavex Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anavex Life Sciences and Reata Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reata Pharmaceuticals are associated (or correlated) with Anavex Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anavex Life Sciences has no effect on the direction of Reata Pharmaceuticals i.e., Reata Pharmaceuticals and Anavex Life go up and down completely randomly.

Pair Corralation between Reata Pharmaceuticals and Anavex Life

Given the investment horizon of 90 days Reata Pharmaceuticals is expected to generate 3.77 times more return on investment than Anavex Life. However, Reata Pharmaceuticals is 3.77 times more volatile than Anavex Life Sciences. It trades about 0.09 of its potential returns per unit of risk. Anavex Life Sciences is currently generating about 0.03 per unit of risk. If you would invest  3,562  in Reata Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of  7,405  from holding Reata Pharmaceuticals or generate 207.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy31.31%
ValuesDaily Returns

Reata Pharmaceuticals  vs.  Anavex Life Sciences

 Performance 
       Timeline  
Reata Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Reata Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Reata Pharmaceuticals is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.
Anavex Life Sciences 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Anavex Life Sciences are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, Anavex Life disclosed solid returns over the last few months and may actually be approaching a breakup point.

Reata Pharmaceuticals and Anavex Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Reata Pharmaceuticals and Anavex Life

The main advantage of trading using opposite Reata Pharmaceuticals and Anavex Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reata Pharmaceuticals position performs unexpectedly, Anavex Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anavex Life will offset losses from the drop in Anavex Life's long position.
The idea behind Reata Pharmaceuticals and Anavex Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities